Human Herpesvirus 8: Biology and Role in the Pathogenesis of Kaposi's Sarcoma and Other AIDS-related Malignancies (Q35086996)

6 August 2017

Human Herpesvirus 8: Biology and Role in the Pathogenesis of Kaposi's Sarcoma and Other AIDS-related Malignancies (English)

1 reference

Kaposi's sarcoma-associated herpesvirus

6 August 2017

0 references

0 references

1 reference

object named as

Human Herpesvirus 8

1 reference

Abel Viejo-Borbolla

1

1 reference

PubMed ID

12642004

6 August 2017

Matthias Ottinger

series ordinal

2

1 reference

PubMed ID

12642004

6 August 2017

Thomas F. Schulz

series ordinal

3

1 reference

6 August 2017

1 April 2003

1 reference

Current infectious disease reports

6 August 2017

1 reference

6 August 2017

5

1 reference

6 August 2017

2

1 reference

6 August 2017

169-175

1 reference

Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8).

6 August 2017

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-003-0054-2

Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-003-0054-2

The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1.

21 January 2018

1 reference

12 December 2020

Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins

1 reference

12 December 2020

Bone marrow failure associated with human herpesvirus 8 infection after transplantation

1 reference

12 December 2020

The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.

1 reference

12 December 2020

The human herpes virus 8-encoded viral FLICE inhibitory protein physically associates with and persistently activates the Ikappa B kinase complex

1 reference

12 December 2020

Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class major histocompatibility complexes to late endocytic compartments

1 reference

12 December 2020

Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene

1 reference

12 December 2020

Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells

1 reference

12 December 2020

The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells

1 reference

12 December 2020

Evidence for concurrent epidemics of human herpesvirus 8 and human immunodeficiency virus type 1 in US homosexual men: rates, risk factors, and relationship to Kaposi's sarcoma

1 reference

12 December 2020

Multiple endocytic trafficking pathways of MHC class I molecules induced by a Herpesvirus protein

1 reference

12 December 2020

Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases

1 reference

12 December 2020

Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue

1 reference

12 December 2020

Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection

1 reference

12 December 2020

High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients.

1 reference

12 December 2020

Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis

1 reference

12 December 2020

Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands.

1 reference

12 December 2020

Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma

1 reference

12 December 2020

Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma

1 reference

12 December 2020

Risk factors for human herpesvirus 8 infection in a cohort of drug users in the Netherlands, 1985-1996.

1 reference

12 December 2020

Human herpesvirus 8 transmission from mother to child and between siblings in an endemic population

1 reference

12 December 2020

Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents

1 reference

12 December 2020

The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen

1 reference

12 December 2020

KSHV/HHV8-associated lymphoproliferations in the AIDS setting

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53

1 reference

12 December 2020

The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors

1 reference

12 December 2020

Herpes viral cyclin/Cdk6 complexes evade inhibition by CDK inhibitor proteins.

1 reference

12 December 2020

Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication

1 reference

12 December 2020

Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease

1 reference

12 December 2020

Risk factors for Kaposi's-sarcoma-associated herpesvirus (KSHV/HHV-8) seropositivity in a cohort of homosexual men, 1981-1996.

1 reference

12 December 2020

Signaling by human herpesvirus 8 kaposin A through direct membrane recruitment of cytohesin-1.

1 reference

12 December 2020

HHV-8 encoded vIRF-1 represses the interferon antiviral response by blocking IRF-3 recruitment of the CBP/p300 coactivators

1 reference

12 December 2020

Seroprevalence of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 in several regions of Italy

1 reference

12 December 2020

Seroepidemiology and molecular epidemiology of Kaposi's sarcoma-associated herpesvirus among Jewish population groups in Israel.

1 reference

12 December 2020

Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy

1 reference

12 December 2020

Kaposi's sarcoma associated herpesvirus (KSHV) or human herpesvirus 8 (HHV8).

1 reference

12 December 2020

Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma

1 reference

12 December 2020

Risk factors for human herpesvirus 8 seropositivity and seroconversion in a cohort of homosexual men

1 reference

12 December 2020

Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene

1 reference

12 December 2020

Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma

1 reference

12 December 2020

The KSHV latency-associated nuclear antigen: a multifunctional protein

1 reference

12 December 2020

The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line

1 reference

12 December 2020

Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent antiapoptotic effects

1 reference

12 December 2020

Inhibition of p53 tumor suppressor by viral interferon regulatory factor

1 reference

12 December 2020

Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen

1 reference

12 December 2020

Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus

1 reference

12 December 2020

Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma.

1 reference

12 December 2020

Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) binds to, and inhibits transactivation of, CREB-binding protein

1 reference

12 December 2020

Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus

1 reference

12 December 2020

10.1007/S11908-003-0054-2

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12642004